GlassScriptPhysician profile
Rae R Huang
NPI 1598192791
$10,581.47
in general payments reported to CMS, 2019-2025
14 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,365 · 2020: $71.89 · 2021: $1,619 · 2022: $600 · 2023: $5,168 · 2024: $386 · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,925.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $4,190.61 | 2023 | Optilight |
| Alcon Vision LLC | $1,661.53 | 2019-2025 | Tryptyr, Clareon, Dailies Total1 |
| Johnson & Johnson Vision Care, INC. | $1,421.55 | 2019-2025 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $518.80 | 2022 | |
| Coopervision INC. | $512.82 | 2019-2025 | Onefit Contact Lens, Paragon Crt |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $498.52 | 2019-2021 | |
| Glaukos Corporation | $495.21 | 2023-2025 | Ce-Marked Kxla System, Photrexa Viscous and Photrexa |
| Bausch & Lomb Americas INC. | $272.89 | 2023-2025 | Infuse, Miebo, Xiidra |
| Visioneering Technologies, INC. | $250.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $209.95 | 2025 | Xdemvy |
| Rxsight INC | $194.79 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Visionary Optics LLC | $179.85 | 2023 | |
| Abbvie INC. | $150.87 | 2022-2025 | |
| Biotissue Holdings INC. | $24.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rae Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.